BioStem Technologies
Blood & Organ Banks · Florida, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2836 Center Port Cir, Pompano Beach, Flo...Phone Number
(954) 380-8342Website
www.biostemlifesciences.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About BioStem Technologies
BioStem Technologies Inc. is a regenerative medicine company headquartered in Pompano Beach, Florida. Publicly traded on the OTC under the ticker BSEM, the company focuses on the development, manufacturing, and commercialization of perinatal tissue allograft products for regenerative therapies. It produces membrane allografts, including the VENDAJE, VENDAJE AC, and VENDAJE OPTIC lines, using a proprietary BioRetain processing method designed to preserve endogenous biological properties. The company operates an AATB accredited, FDA registered, cGMP compliant laboratory and provides end-to-end solutions as a Contract Development and Manufacturing Organization (CDMO) for biologics and Human Cellular, Tissue and Gene Therapies.Explore more
Popular SearchesBioStem Technologies IncBioStem Life SciencesSIC Code 28,283NAICS Code 32,325Show moreSell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is BioStem Technologies your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at BioStem Technologies
Product Launch: Get notified when BioStem Technologies launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if BioStem Technologies had a recent Job posting/layoffs
Earning: See what the market has to say on BioStem Technologies recently announced quarterly report
Check if BioStem Technologies has recently received funding, and reach out quickly before it becomes old news!
Check out if BioStem Technologies is spiking on competitors!
BioStem Technologies, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once BioStem Technologies has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
BioStem Technologies is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
BioStem Technologies is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about BioStem Technologies.
BioStem Technologies Tech Stack
A closer look at the technologies used by BioStem Technologies
BioStem Technologies News & Media
BioStem Life Sciences Receives Accreditation by The American Association of Tissue Banks® (AATB®)
Pompano Beach, FL, July 15, 2020 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) a leading life sciences company specializing in the development and sale of perinatal tissue-based allografts for use in regenerative therapies, today announced that its subsidiary, BioStem Life Sciences has been awarded the prestigious accolade of accreditation by the American Association of Tissue Banks® (AATB®). BioStem Life Sciences is now accredited for Donor Eligibility Assessment, Processing,BioStem Technologies, Inc. Announces Tissue Bank Certification in California and Maryland
Pompano Beach, FL, June 26, 2020 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company") a leading life sciences company specializing in perinatal tissue-based allografts for use in regenerative therapies, today announced that its subsidiary, BioStem Life Sciences, has added California and Maryland to its list of tissue bank licenses issued by the individual state’s Department of Health.BioStem Life Sciences Announces ISBT 128 Registration via ICCBBA
POMPANO BEACH, Fla. , March 27, 2020 (GLOBE NEWSWIRE) -- BioStem Life Sciences, a wholly owned subsidiary of BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company") a leading life sciences company specializing in perinatal tissue-based allografts for use in regenerative therapies, today announced that it had received it’s ISBT 128 Registration from the ICCBBA.BioStem Life Sciences Announces Expansion; Contract Manufacturing Capabilities, and Research and Development Laboratory
Pompano Beach, FL, March 13, 2020 (GLOBE NEWSWIRE) -- BioStem Life Sciences, a wholly owned subsidiary of BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company") a leading life sciences company specializing in perinatal tissue-based allografts for use in regenerative therapies, today announced the buildout of a brand new R&D lab. Situated in the Company's 6,100 sq. Ft., state-of-the-art, FDA registered, cGMP facility, this new lab will support the research and development pi
Read more news
Top Blood & Organ Banks Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding BioStem Technologies
Sign Up For FreeTo access detailed company insights
BioStem Technologies Inc. is a regenerative medicine company headquartered in Pompano Beach, Florida. Publicly traded on the OTC under the ticker BSEM, the company focuses on the development, manufacturing, and commercialization of perinatal tissue allograft products for regenerative therapies. It produces membrane allografts, including the VENDAJE... Read More
